Dahlberg S - Search Results

1

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.

Dana BW, Dahlberg S, Miller TP, Hartsock RJ, Balcerzak S, Coltman CA, Carden JO, Hartley K, Fisher RI. Dana BW, et al. Among authors: dahlberg s. J Clin Oncol. 1990 Jul;8(7):1155-62. doi: 10.1200/JCO.1990.8.7.1155. J Clin Oncol. 1990. PMID: 1694233

2

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.

Miller TP, Dahlberg S, Weick JK, Files JC, Eyre HJ, Pendergrass KB, Fisher RI. Miller TP, et al. Among authors: dahlberg s. J Clin Oncol. 1990 Dec;8(12):1951-8. doi: 10.1200/JCO.1990.8.12.1951. J Clin Oncol. 1990. PMID: 1700079 Clinical Trial.

3

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.

Weick JK, Dahlberg S, Fisher RI, Dana B, Miller TP, Balcerzak SP, Pierce HI. Weick JK, et al. Among authors: dahlberg s. J Clin Oncol. 1991 May;9(5):748-53. doi: 10.1200/JCO.1991.9.5.748. J Clin Oncol. 1991. PMID: 1707955 Clinical Trial.

4

A clinical phase II study of ProMACE-CytaBOM.

Dahlberg S, Miller TP, Fisher RI. Dahlberg S, et al. J Clin Oncol. 1991 May;9(5):888. J Clin Oncol. 1991. PMID: 1707958 No abstract available.

5

Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study.

Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. Miller TP, et al. Among authors: dahlberg s. J Clin Oncol. 1991 Jul;9(7):1204-9. doi: 10.1200/JCO.1991.9.7.1204. J Clin Oncol. 1991. PMID: 2045860 Clinical Trial.

6

Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Fisher RI, Miller TP, Dana BW, Jones SE, Dahlberg S, Coltman CA Jr. Fisher RI, et al. Among authors: dahlberg s. Semin Hematol. 1987 Apr;24(2 Suppl 1):21-5. Semin Hematol. 1987. PMID: 2438778 Clinical Trial.

7

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI. Miller TP, et al. Among authors: dahlberg s. Semin Hematol. 1988 Apr;25(2 Suppl 2):17-22. Semin Hematol. 1988. PMID: 2456619

8

Phase II evaluation of bisantrene in acute leukemia. A Southwest Oncology Group Study.

Mills GM, Dahlberg S, Cowan J, Neilan BA, Gumbart CH, Hussein K, Coltman CA Jr. Mills GM, et al. Among authors: dahlberg s. Am J Clin Oncol. 1989 Dec;12(6):507-10. doi: 10.1097/00000421-198912000-00010. Am J Clin Oncol. 1989. PMID: 2589232

9

Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trial.

Dana B, Dahlberg S, Schnitzer B, Kjeldsberg CR, Jones SE, Carden J, Mundis R, Tranum B. Dana B, et al. Among authors: dahlberg s. Invest New Drugs. 1989 Jul;7(2-3):247-50. doi: 10.1007/BF00170868. Invest New Drugs. 1989. PMID: 2793382 Free article.

10

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP. Fisher RI, et al. Among authors: dahlberg s. Ann Oncol. 1994;5 Suppl 2:91-5. doi: 10.1093/annonc/5.suppl_2.s91. Ann Oncol. 1994. PMID: 7515652 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters